{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:01:09Z","timestamp":1767135669912,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd008190.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000}}],"reference-count":225,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd008190.pub3","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T09:55:22Z","timestamp":1663926922000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Appetite stimulants for people with cystic fibrosis"],"prefix":"10.1002","volume":"2022","author":[{"given":"Diane","family":"McTavish","sequence":"additional","affiliation":[{"name":"Adult Cystic Fibrosis Unit; Queen Elizabeth University Hospital; Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Thornton","sequence":"additional","affiliation":[{"name":"Centre for Clinical Practice; National Institute for Health and Care Excellence; Manchester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"10.1002\/14651858.CD008190.pub3-BIB0001|cit1","unstructured":"Cyproheptadine as an appetite stimulant in patients with cystic fibrosis and your effect on gain weight trialsearch.who.int\/Trial2.aspx?TrialID=ACTRN12611000127909"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2223\/JPED.2174","article-title":"A randomized, double-blind, placebo-controlled trial of cyproheptadine for appetite stimulation in cystic fibrosis","volume":"88","author":"Epifanio","year":"2012","journal-title":"Journal of Pediatrics (Rio J)"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0003|cit3","first-page":"322","article-title":"Effects of megestrol acetate on energy intake, weight gain, body composition and resting energy expenditure in cystic fibrosis patients","volume":"30 Suppl 20","author":"Eubanks","year":"2000","journal-title":"Pediatric Pulmonology"},{"issue":"4","key":"10.1002\/14651858.CD008190.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1067\/mpd.2002.121936","article-title":"Effects of megestrol acetate on weight gain, body composition, and pulmonary function in patients with cystic fibrosis","volume":"140","author":"Eubanks","year":"2002","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD008190.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/ppul.20265","article-title":"Long-term trial of cyproheptadine as an appetite stimulant in cystic fibrosis","volume":"40","author":"Homnick","year":"2005","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0006|cit6","first-page":"343","article-title":"The use of cyproheptadine as an appetite stimulant in cystic fibrosis patients [abstract]","volume":"36 Suppl 25","author":"Homnick","year":"2003","journal-title":"Pediatric Pulmonology"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ppul.20043","article-title":"Cyproheptadine is an effective appetite stimulant in cystic fibrosis","volume":"38","author":"Homnick","year":"2004","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0008|cit8","first-page":"330","article-title":"Long-term trial of cyproheptadine as an appetite stimulant in cystic fibrosis [abstract]","volume":"38 Suppl 27","author":"Homnick","year":"2004","journal-title":"Pediatric Pulmonology"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/jam.2006.0593","article-title":"The effect of a first-generation antihistamine on sputum viscoelasticity in cystic fibrosis","volume":"20","author":"Homnick","year":"2007","journal-title":"Journal of Aerosol Medicine"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00005176-199910000-00120","article-title":"Leptin level in children with cystic fibrosis, effect of megestrol acetate treatment [abstract]","volume":"29","author":"Marchand","year":"1999","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD008190.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00005176-200009000-00012","article-title":"Randomized, double-blind, placebo-controlled pilot trial of megestrol acetate in malnourished children with cystic fibrosis","volume":"31","author":"Marchand","year":"2000","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0012|cit12","unstructured":"Improving mental health of young Australians with chronic illness: a pilot study of the effectiveness of online self-compassion training trialsearch.who.int\/Trial2.aspx?TrialID=ACTRN12619000572167"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/07315724.1998.10718788","article-title":"Anabolic effects of growth hormone treatment in young children with cystic fibrosis","volume":"17","author":"Alemzadeh","year":"1998","journal-title":"Journal of the American College of Nutrition"},{"issue":"9","key":"10.1002\/14651858.CD008190.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/S0004-27302011000900001","article-title":"Growth hormone in children and adolescents with cystic fibrosis","volume":"55","author":"Amorim","year":"2011","journal-title":"Arquivos Brasileiros de Endocrinologia e Metabologia"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0015|cit15","first-page":"343","article-title":"Dronabinol, an effective and safe appetite stimulant in cystic fibrosis [abstract]","volume":"36 Suppl 25","author":"Anstead","year":"2003","journal-title":"Pediatric Pulmonology"},{"issue":"8457","key":"10.1002\/14651858.CD008190.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0140-6736(85)92929-0","article-title":"Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis","volume":"2","author":"Auerbach","year":"1985","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0017|cit17","first-page":"322","article-title":"Long-term alternate day prednisone therapy in cystic fibrosis","volume":"9 Suppl 5","author":"Donati","year":"1990","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1471-2431-14-70","article-title":"Open randomised prospective comparative multi-centre intervention study of patients with cystic fibrosis and early diagnosed diabetes mellitus","volume":"14","author":"Ballmann","year":"2014","journal-title":"BMC Pediatrics"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0019|cit19","first-page":"421, Abstract n","article-title":"Repaglinide versus insulin in the treatment of CFRD diagnosed by screening: an open prospective randomized study [abstract]","volume":"48 Suppl 26","author":"Ballmann","year":"2013","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"S32, Abstract n","DOI":"10.1016\/S1569-1993(13)60095-8","article-title":"Treatment of early diagnosed CFRD with oral drugs versus insulin: an open prospective randomized study [abstract]","volume":"12 Suppl 1","author":"Ballmann","year":"2013","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S2213-8587(17)30400-X","article-title":"Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial","volume":"6","author":"Ballmann","year":"2018","journal-title":"Lancet Diabetes & Endocrinology"},{"key":"#cr-split#-10.1002\/14651858.CD008190.pub3-BIB0022|cit22.1","unstructured":"Correction: repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial (Lancet Diabetes & Endocrinology (2018) 6"},{"key":"#cr-split#-10.1002\/14651858.CD008190.pub3-BIB0022|cit22.2","doi-asserted-by":"crossref","unstructured":"(2) (114-21), (S221385871730400X) (10.1016\/S2213-8587(17)30400-X)) Lancet Diabetes & Endocrinology 2019 7 4 e4 10.1016\/S2213-8587(17)30400-X)","DOI":"10.1016\/S2213-8587(19)30092-0"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0023|cit23","unstructured":"Early diagnosis of diabetes mellitus in patients with cystic fibrosis clinicaltrials.gov\/show\/NCT00662714"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcf.2013.06.001","article-title":"Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test","volume":"13","author":"Schmid","year":"2014","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0025|cit25","first-page":"261","article-title":"Coping and learning to manage stress in cystic fibrosis via telehealth: RCT pilot results","volume":"55 Suppl 2","author":"Bathgate","year":"2020","journal-title":"Pediatric\u00a0Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S1569-1993(21)00978-4","article-title":"Randomised controlled trial piloting the \u201cCoping and Learning to Manage Stress in CF\u201d (CALM) telehealth intervention to reduce depressive and anxious symptoms in adults with cystic fibrosis","volume":"20 Suppl 1","author":"Bathgate","year":"2021","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0027|cit27","first-page":"411","article-title":"Telehealth cognitive behavioral stress management - preliminary pilot highlights and challenges","volume":"54 Suppl 2","author":"Bathgate","year":"2019","journal-title":"Pediatric\u00a0Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0028|cit28","unstructured":"Telehealth cognitive behavioral stress management for adults with cystic fibrosis clinicaltrials.gov\/show\/NCT03560726"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0029|cit29","first-page":"456","article-title":"Retrospective audit of nutritional status of paediatric cystic fibrosis patients","volume":"52 Suppl 47","author":"Battersby","year":"2017","journal-title":"Pediatric Pulmonology"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0030|cit30","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004310.pub2","article-title":"Megestrol acetate for treatment of anorexia-cachexia syndrome","author":"Berenstein","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD008190.pub3-BIB0031|cit31","first-page":"138","article-title":"Treating parents of children with cystic fibrosis with unresolved grief","volume":"23","author":"Branch-Smith","year":"2018","journal-title":"Respirology"},{"issue":"Suppl 17","key":"10.1002\/14651858.CD008190.pub3-BIB0032|cit32","first-page":"355","article-title":"Insulin-like growth factor-1 enhances linear growth in undernourished prepubertal children with cystic fibrosis","volume":"26","author":"Bucuvalas","year":"1998","journal-title":"Pediatric Pulmonology"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00005176-200111000-00012","article-title":"Effect of insulinlike growth factor-1 treatment in children with cystic fibrosis","volume":"33","author":"Bucuvalas","year":"2001","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0034|cit34","first-page":"359","article-title":"The effect of megestrol on nutritional status in patients with cystic fibrosis","volume":"26 Suppl 17","author":"Canfield","year":"1998","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0035|cit35","first-page":"13","volume-title":"Nutritional Management of Cystic Fibrosis: a Consensus Report","author":"CF Trust Nutrition Working Group","year":"2002"},{"issue":"6","key":"10.1002\/14651858.CD008190.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1365-277X.2007.00824.x","article-title":"Appetite stimulants in cystic fibrosis: a systematic review","volume":"20","author":"Chinuck","year":"2007","journal-title":"Journal of Human Nutrition and Dietetics"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008190.pub3-BIB0037|cit37","first-page":"S239","article-title":"Identifying and managing malnutrition stemming from different causes","volume":"27","author":"Chung","year":"2006","journal-title":"Peritoneal Dialysis International"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/S1569-1993(20)30619-6","article-title":"Successful trial with an appetite stimulator in 2 siblings with cystic fibrosis with persistent failure to thrive and poor appetite","volume":"19 Suppl 2","author":"Claes","year":"2020","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jcf.2008.02.002","article-title":"Plasma ghrelin and leptin in adult cystic fibrosis patients","volume":"7","author":"Cohen","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000254486","article-title":"Ghrelin receptor expression in lymphocytes isolated from adult cystic fibrosis patients","volume":"79","author":"Cohen","year":"2010","journal-title":"Respiration"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/S1569-1993(08)60219-2","article-title":"Intravenous methylprednisolone pulse therapy vs.oral prednisone for allergic bronchopulmonary aspergillosis (ABPA) in CF","volume":"7 Suppl 2","author":"Cohen-Cymberknoh","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0042|cit42","first-page":"S86, Abstract n","article-title":"Use of megestrol acetate to improve body weight in malnourished adult cystic fibrosis patients","volume":"2 Suppl 1","author":"Crawley","year":"2003","journal-title":"Journal of Cystic Fibrosis"},{"issue":"3","key":"10.1002\/14651858.CD008190.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/jc.2003-031409","article-title":"Effects of glutamine and recombinant human growth hormone on protein metabolism in prepubertal children with cystic fibrosis","volume":"89","author":"Darmaun","year":"2004","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0044|cit44","first-page":"323","article-title":"Use of glutamine and recombinant human growth hormone in children with cystic fibrosis","volume":"30 Suppl 20","author":"Schaeffer","year":"2000","journal-title":"Pediatric Pulmonology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008190.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"S12, Abstract n","DOI":"10.1016\/S1569-1993(14)60040-0","article-title":"A placebo-controlled trial of insulin therapy with or without adjuvant metformin in patients with cystic fibrosis-related diabetes (CFRD)","volume":"13","author":"Lind van Wijngaarden-van den Berg","year":"2014","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1089\/thy.2007.0018","article-title":"Appetite regulation: an overview","volume":"17","author":"Dhillo","year":"2007","journal-title":"Thyroid"},{"issue":"4","key":"10.1002\/14651858.CD008190.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1378\/chest.07-0843","article-title":"Oral corticosteroids therapy in cystic fibrosis patients hospitalized for pulmonary exacerbation: a pilot study","volume":"132","author":"Dovey","year":"2007","journal-title":"Chest"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0048|cit48","first-page":"301","article-title":"A randomised, double-blind, placebo-controlled trial of oral corticosteroid therapy in cystic fibrosis patients hospitalized for pulmonary exacerbations [abstract]","volume":"38 Suppl 27","author":"Dovey","year":"2004","journal-title":"Pediatric Pulmonology"},{"issue":"Suppl","key":"10.1002\/14651858.CD008190.pub3-BIB0049|cit49","first-page":"S83","article-title":"The use of megestrol acetate in the treatment of cachexia associated with cystic fibrosis [abstract]","volume":"54","author":"Dowsett","year":"1999","journal-title":"Netherlands Journal of Medicine"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0050|cit50","unstructured":"Web-based psychological support program for parental caregivers of children with rare chronic diseases trialsearch.who.int\/Trial2.aspx?TrialID=DRKS00010979"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0051|cit51","first-page":"360","article-title":"Megesterol acetate: treatment of growth failure in children with cystic fibrosis [abstract]","volume":"26 Suppl 17","author":"Durant","year":"1998","journal-title":"Pediatric Pulmonlogy"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0052|cit52","first-page":"360","article-title":"Megesterol acetate effects on weight in CF subject exhibiting growth failure: a case controlled study [abstract]","volume":"26 Suppl 17","author":"Eubanks","year":"1998","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0053|cit53","unstructured":"Feasibility trial of an online intervention for symptoms of depression and anxiety in adolescents with chronic medical conditions (youthCOACH-CD) trialsearch.who.int\/Trial2.aspx?TrialID=DRKS00016714"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12887-022-03134-3","article-title":"Feasibility and potential efficacy of a guided internet- and mobile-based CBT for adolescents and young adults with chronic medical conditions and comorbid depression or anxiety symptoms (youthCOACHCD): a randomized controlled pilot trial","volume":"22","author":"Geirhos","year":"2022","journal-title":"BMC Pediatrics"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0055|cit55","first-page":"456, Abstract n","article-title":"Screening for depression in caregivers of children with cystic fibrosis","volume":"51 Suppl 45","author":"Goetz","year":"2016","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/db19-708-P","article-title":"Effectiveness of cho-counting on glycometabolic control and comparison between the methods of I\/cho ratio calculation in subjects with cystic fibrosis-related diabetes (CFRD)","volume":"68 Suppl 1","author":"Grancini","year":"2019","journal-title":"Diabetes"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/adc.71.1.35","article-title":"Interleukin-1 alpha, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone","volume":"71","author":"Greally","year":"1994","journal-title":"Archives of Disease in Childhood"},{"issue":"Suppl 15","key":"10.1002\/14651858.CD008190.pub3-BIB0058|cit58","first-page":"259s","article-title":"Effect of prednisolone on airways obstruction in patients with cystic fibrosis [abstract]","volume":"5","author":"Greally","year":"1992","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0059|cit59","unstructured":"Greally P Sampson AP Piper PJ Price JF Prednisolone reduces airways obstruction in children with cystic fibrosis 11th International Cystic Fibrosis Congress; 1992 Aug 22-27; Dubin, Ireland 1992 TS12"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.prrv.2015.07.014","article-title":"Anabolic agent use in adults with cystic fibrosis","volume":"16 Suppl 1","author":"Green","year":"2015","journal-title":"Paediatric Respiratory Reviews"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jcf.2007.07.004","article-title":"Glargine versus NPH insulin in cystic fibrosis related diabetes","volume":"7","author":"Grover","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1016\/S1569-1993(20)30610-X","article-title":"Use of an appetite stimulant (Periactin) in paediatric patients with cystic fibrosis","volume":"19 Suppl 2","author":"Grunert","year":"2020","journal-title":"Journal of Cystic Fibrosis"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0063|cit63","first-page":"7","article-title":"Evaluating the use of megesterol acetate in Caen and Lisieux CF Centers","volume":"10","author":"Guillot","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S1569-1993(11)60310-X","article-title":"Evaluating the use of megestrol acetate in Caen and Lisieux CF Centers (2007-2010)","volume":"10 Suppl 1","author":"Guillot","year":"2011","journal-title":"Journal of Cystic Fibrosis"},{"issue":"1 Pt 2","key":"10.1002\/14651858.CD008190.pub3-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S0022-3476(97)70015-5","article-title":"Effects of growth hormone treatment in children with cystic fibrosis: The National Cooperative Growth Study experience","volume":"131","author":"Hardin","year":"1997","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0066|cit66","first-page":"357","article-title":"Growth hormone improves lean body mass in prepubertal CF children","volume":"26 Suppl 17","author":"Hardin","year":"1998","journal-title":"Pediatric Pulmonology"},{"issue":"9","key":"10.1002\/14651858.CD008190.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1210\/jcem.86.9.7822","article-title":"Growth hormone decreases protein catabolism in children with cystic fibrosis","volume":"86","author":"Hardin","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1067\/mpd.2001.117578","article-title":"Growth hormone improves clinical status in prepubertal children with cystic fibrosis: results of a randomized controlled trial","volume":"139","author":"Hardin","year":"2001","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0069|cit69","first-page":"297","article-title":"Growth hormone improves clinical status in cystic fibrosis children","volume":"28 Suppl 19","author":"Hardin","year":"1999","journal-title":"Pediatric Pulmonology"},{"issue":"10","key":"10.1002\/14651858.CD008190.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1055\/s-2007-978949","article-title":"Growth hormone improves weight velocity and height velocity in prepubertal children with cystic fibrosis","volume":"30","author":"Hardin","year":"1998","journal-title":"Hormone and Metabolic Research"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0071|cit71","unstructured":"Growth hormone treatment study in children with cystic fibrosis clinicaltrials.gov\/ct2\/show\/NCT00256555"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0072|cit72","first-page":"343","article-title":"Use of growth hormone in adults with CF","volume":"38 Suppl 27","author":"Hardin","year":"2004","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD008190.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1515\/JPEM.2005.18.6.589","article-title":"Growth hormone improves bone mineral content in children with cystic fibrosis","volume":"18","author":"Hardin","year":"2005","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"issue":"3","key":"10.1002\/14651858.CD008190.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.jpeds.2004.10.037","article-title":"Growth hormone treatment enhances nutrition and growth in children with cystic fibrosis receiving enteral nutrition","volume":"146","author":"Hardin","year":"2005","journal-title":"Journal of Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2265.2005.02259.x","article-title":"A retrospective study of growth hormone used in adolescents with cystic fibrosis","volume":"62","author":"Hardin","year":"2005","journal-title":"Clinical Endocrinology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0076|cit76","first-page":"343, Abstract n","article-title":"Growth hormone improves bone mineralization in prepubertal children with CF - results of a multicenter study","volume":"38 Suppl 27","author":"Hardin","year":"2004","journal-title":"Pediatric Pulmonology"},{"issue":"12","key":"10.1002\/14651858.CD008190.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1210\/jc.2006-1101","article-title":"Growth hormone treatment improves growth and clinical status in prepubertal children with cystic fibrosis: results of a multicenter randomized controlled trial","volume":"91","author":"Hardin","year":"2006","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0078|cit78","first-page":"338","article-title":"Multicentre trial of growth hormone in children with CF","volume":"32 Suppl 22","author":"Hardin","year":"2001","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0079|cit79","first-page":"337","article-title":"Growth hormone improves pulmonary function, weight, and height - results from a multicenter study","volume":"34 Suppl 24","author":"Hardin","year":"2002","journal-title":"Pediatric Pulmonology"},{"issue":"Suppl 5","key":"10.1002\/14651858.CD008190.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000110603","article-title":"A review of the management of two common clinical problems found in patients with cystic fibrosis: cystic fibrosis-related diabetes and poor growth","volume":"68","author":"Hardin","year":"2007","journal-title":"Hormone Research"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.clnesp.2020.08.006","article-title":"Addressing nutritional failure in a cystic fibrosis patient using nutritional and psychological intervention","volume":"40","author":"Hider","year":"2020","journal-title":"Clinical Nutrition ESPEN"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0082|cit82","first-page":"190","article-title":"Impact of disclosure to colleagues, friends and romantic partners on older adolescent and adult psychosocial outcome","volume":"50 Suppl 41","author":"Borschuk","year":"2015","journal-title":"Pediatric\u00a0Pulmonology"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jcf.2016.02.011","article-title":"Disease disclosure in individuals with cystic fibrosis: association with psychosocial and health outcomes","volume":"15","author":"Borschuk","year":"2016","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1037\/hea0000136","article-title":"Medication beliefs mediate between depressive symptoms and medication adherence in cystic fibrosis","volume":"34","author":"Hilliard","year":"2015","journal-title":"Health Psychology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0085|cit85","unstructured":"Building adherence to live with and navigate my cystic fibrosis (CF) experience clinicaltrials.gov\/show\/NCT01013896"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0086|cit86","first-page":"133","article-title":"Building adherence to live and navigate my CF experience: the balance study","volume":"48 Suppl 36","author":"Riekert","year":"2013","journal-title":"Pediatric\u00a0Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0087|cit87","first-page":"133","article-title":"Building adherence to live and navigate my CF experience: the balance study","volume":"48 Suppl 36","author":"Riekert","year":"2013","journal-title":"Pediatric Pulmonology"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008190.pub3-BIB0088|cit88","first-page":"263","article-title":"Telephone cognitive behavioral therapy treatment of insomnia for people with cystic fibrosis: a pilot randomized trial","volume":"55","author":"Hjelm","year":"2020","journal-title":"Pediatric Pulmonology"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1099-0496(199608)22:2<90::AID-PPUL2>3.0.CO;2-N","article-title":"Anabolic effect of biosynthetic growth hormone in cystic fibrosis patients","volume":"22","author":"Huseman","year":"1996","journal-title":"Pediatric Pulmonology"},{"issue":"4","key":"10.1002\/14651858.CD008190.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1249\/00005768-200204000-00001","article-title":"Effect of growth hormone on exercise tolerance in children with cystic fibrosis","volume":"34","author":"H\u00fctler","year":"2002","journal-title":"Medicine and Science in Sports and Exercise"},{"issue":"Suppl","key":"10.1002\/14651858.CD008190.pub3-BIB0091|cit91","first-page":"S17","article-title":"Growth hormone enhances peak performance in cystic fibrosis","volume":"19","author":"Hutler","year":"1998","journal-title":"International Journal of Sports Medicine"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0092|cit92","first-page":"394","article-title":"Patterns of change in body composition on treatment with lumacaftor-ivacaftor in severe cystic fibrosis lung disease: early gains in weight and fat mass plateau by one year","volume":"53 Suppl 2","author":"King","year":"2018","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD008190.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/(SICI)1099-0496(200003)29:3<244::AID-PPUL16>3.0.CO;2-#","article-title":"Role of progestational agents in the treatment of undernourished patients with cystic fibrosis","volume":"29","author":"Kissner","year":"2000","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1016\/j.jcf.2019.08.010","article-title":"Growth failure and treatment in cystic fibrosis","volume":"18 Suppl 2","author":"Le","year":"2019","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0095|cit95","first-page":"113","article-title":"The gastroenterologist approach to growth in CF","volume":"54 Suppl 2","author":"Leung","year":"2019","journal-title":"Pediatric Pulmonology"},{"issue":"6","key":"10.1002\/14651858.CD008190.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1183\/09031936.01.00065701","article-title":"Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients","volume":"17","author":"Linnane","year":"2001","journal-title":"European Respiratory Journal"},{"issue":"4","key":"10.1002\/14651858.CD008190.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpainsymman.2003.09.007","article-title":"Systematic review of megestrol acetate in the treatment of anorexia-cachexia syndrome","volume":"27","author":"L\u00f3pez","year":"2004","journal-title":"Journal of Pain and Symptom Management"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1200\/JCO.1993.11.1.152","article-title":"Body-composition changes in patients who gain weight while receiving megestrol acetate","volume":"11","author":"Loprinzi","year":"1993","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0099|cit99","unstructured":"Effectiveness and cost-effectiveness of guided internet-and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACHcd): a multicentre randomized controlled trial with a 12-month follow-up trialsearch.who.int\/Trial2.aspx?TrialID=DRKS00017161"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s13063-019-4041-9","article-title":"Effectiveness and cost-effectiveness of guided Internet- and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACHCD): study protocol for a multicentre randomized controlled trial","volume":"21","author":"Lunkenheimer","year":"2020","journal-title":"Trials"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"253. Online Sup","DOI":"10.1186\/s13063-019-4041-9","article-title":"Effectiveness and cost-effectiveness of guided Internet- and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACHCD): study protocol for a multicentre randomized controlled trial","volume":"21","author":"Lunkenheimer","year":"2020","journal-title":"Trials"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0102|cit102","first-page":"442, Abstract n","article-title":"Trajectories of depression and anxiety in adolescents with CF","volume":"49 Suppl 38","author":"McLean","year":"2014","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0103|cit103","first-page":"386","article-title":"Linear growth in children receiving ivacaftor or ivacaftor-lumacaftor for cystic fibrosis","volume":"53 Suppl 2","author":"McLearn-Montz","year":"2018","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"S82, Abstract n","DOI":"10.1016\/S1569-1993(09)60322-2","article-title":"Efficacy of slow release insulin in patients with cystic fibrosis and glucide intolerance [abstract]","volume":"8 Suppl 2","author":"Minicucci","year":"2009","journal-title":"Journal of Cystic Fibrosis"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1399-5448.2011.00810.x","article-title":"Slow-release insulin in cystic fibrosis patients with glucose intolerance: a randomized clinical trial","volume":"13","author":"Minicucci","year":"2012","journal-title":"Pediatric Diabetes"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"S6, Abstract no","DOI":"10.1016\/S1569-1993(08)60493-2","article-title":"New diagnostic and therapeutic approaches in cystic fibrosis related diabetes (CFRD) [abstract]","volume":"7 Suppl 3","author":"Minicucci","year":"2008","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0107|cit107","first-page":"335, Abstract n","article-title":"Insulin and glucose excursion following pre-meal insulin lispro or repaglinide in CFRD","volume":"32 Suppl 22","author":"Milla","year":"2001","journal-title":"Pediatric Pulmonology"},{"issue":"10","key":"10.1002\/14651858.CD008190.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2337\/diacare.24.10.1706","article-title":"Insulin and glucose excursion following premeal insulin lispo or repaglinide in cystic fibrosis-related diabetes","volume":"24","author":"Moran","year":"2001","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1002\/14651858.CD008190.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis related diabetes without fasting hyperglycemia: results of the CFRDT Trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0110|cit110","unstructured":"Diabetes therapy to improve BMI and lung function in CF clinicaltrials.gov\/show\/NCT00072904"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/(SICI)1099-0496(199911)28:5<380::AID-PPUL11>3.0.CO;2-A","article-title":"Treatment of anorexia and weight loss with megesterol acetate in patients with cystic fibrosis","volume":"28","author":"Nasr","year":"1999","journal-title":"Pediatric Pulmonolgy"},{"issue":"3","key":"10.1002\/14651858.CD008190.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ppul.20766","article-title":"Appetite stimulants use in cystic fibrosis","volume":"43","author":"Nasr","year":"2008","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0306-4530(02)00114-2","article-title":"A review of the effect of atypical antipsychotics on weight","volume":"28","author":"Nasrallah","year":"2003","journal-title":"Psychoneuroendrocrinology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0114|cit114","unstructured":"Growth hormone use in cystic fibrosis - a multicenter study clinicaltrials.gov\/show\/NCT00005112"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0115|cit115","unstructured":"Phase II study of growth hormone in children with cystic fibrosis clinicaltrials.gov\/show\/NCT00016445"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0116|cit116","unstructured":"Growth hormone therapy for wasting in cystic fibrosis clinicaltrials.gov\/ct2\/show\/NCT00803179"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0117|cit117","unstructured":"Cystic fibrosis (CF) exacerbation and insulin treatment clinicaltrials.gov\/show\/nct01149005"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0118|cit118","unstructured":"Project UPLIFT to reduce anxiety and depression in CF patients clinicaltrials.gov\/show\/NCT03139266"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0119|cit119","unstructured":"Effect of a family empowerment program on coping, problem solving in parents, and quality of life in children with cystic fibrosis clinicaltrials.gov\/show\/NCT03800459"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0120|cit120","first-page":"323","article-title":"Adrenal suppression in children with cystic fibrosis treated with megesterol acetate [abstract]","volume":"30 Suppl 20","author":"Newkirk","year":"2000","journal-title":"Pediatric Pulmonology"},{"issue":"Suppl 4","key":"10.1002\/14651858.CD008190.pub3-BIB0121|cit121","first-page":"A61","article-title":"A CFRD double-blind parallel placebo controlled randomised study of oral prednisolone in acute respiratory exacerbations in children with cystic fibrosis [abstract]","volume":"53","author":"Nyamugunduru","year":"1998","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0122|cit122","unstructured":"Nyamugunduru G Desai M Spencer D Clarke J Weller P A double-blind parallel placebo-controlled randomised study of the addition of short-course oral prednisolone in treatment of acute respiratory exacerbations in children with cystic fibrosis 22nd European Cystic Fibrosis Conference; 1998 Jun 13-19; Berlin, Germany 1998 79"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0123|cit123","unstructured":"Nyamugunduru G Desai M Weller PH Spencer DA The effect of oral prednisolone on serum interleukin-8 concentrations in acute respiratory exacerbations in children with cystic fibrosis 13th International Cystic Fibrosis Congress; 2000 Jun 4-8; Stockholm, Sweden 2000 183"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0124|cit124","first-page":"476","article-title":"ACT via telehealth: acceptance-based behavioral therapy for anxiety and depression among individuals with cystic fibrosis","volume":"52 Suppl 47","author":"O'Hayer","year":"2017","journal-title":"Pediatric\u00a0Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0125|cit125","unstructured":"Acceptance and commitment therapy vs. supportive psychotherapy with cystic fibrosis patients clinicaltrials.gov\/show\/NCT04114227"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0126|cit126","first-page":"421","article-title":"Act with CF next directions: design of a multisite, randomized controlled trial of telehealth acceptance and commitment therapy vs supportive psychotherapy for anxiety and depression","volume":"54 Suppl\u00a02","author":"O'Hayer","year":"2019","journal-title":"Pediatric\u00a0Pulmonology"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcf.2020.11.013","article-title":"ACT with CF: a telehealth and in-person feasibility study to address anxiety and depressive symptoms among people with cystic fibrosis","volume":"20","author":"O'Hayer","year":"2021","journal-title":"Journal of Cystic Fibrosis"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF00614391","article-title":"Lack of effect of the appetite stimulant pizotifen on the absorption of isonicotinylhydrazine","volume":"7","author":"Ohnhaus","year":"1974","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/thx.41.1.34","article-title":"Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis","volume":"41","author":"Pantin","year":"1986","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0130|cit130","unstructured":"Stead RJ Pantin CFA Hodson ME Batten JC Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis 13th Annual Meeting of the European Working Group for Cystic Fibrosis; 1985 Nov 3-8; Jerusalem, Israel 1985 112"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.schres.2008.09.025","article-title":"Weight effects associated with antipsychotics: a comprehensive database analysis","volume":"110","author":"Parsons","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"S90, Abstract n","DOI":"10.1016\/S1569-1993(10)60349-9","article-title":"Promoting weight gain with olanzapine in underweight adults with cystic fibrosis [abstract]","volume":"9 Suppl 1","author":"Paterson","year":"2010","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"e1211","DOI":"10.1542\/peds.2010-2007","article-title":"Recombinant human growth hormone in the treatment of patients with cystic fibrosis","volume":"125","author":"Phung","year":"2010","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/S1569-1993(16)30439-8","article-title":"Evaluation of the use of megestrol acetate (MA) in adults with cystic fibrosis (CF)","volume":"15 Suppl 1","author":"Price","year":"2016","journal-title":"Journal of Cystic Fibrosis"},{"issue":"47","key":"10.1002\/14651858.CD008190.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"20571","DOI":"10.1073\/pnas.1015281107","article-title":"Pigs and humans with cystic fibrosis have reduced insulin-like growth factor (IGF1) levels at birth","volume":"107","author":"Rogan","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"4","key":"10.1002\/14651858.CD008190.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0022-3476(95)70343-8","article-title":"A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis. Cystic Fibrosis Foundation Prednisone Trial Group","volume":"126","author":"Eigen","year":"1995","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0137|cit137","first-page":"313","article-title":"Longitudinal study in bone absorptiometry in children with cystic fibrosis enrolled in steroid therapy [abstract]","volume":"10 Suppl 6","author":"Hsu","year":"1991","journal-title":"Pediatric Pulmonology"},{"issue":"12","key":"10.1002\/14651858.CD008190.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJM200003233421204","article-title":"Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis","volume":"342","author":"Lai","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0139|cit139","first-page":"297","article-title":"Long-term growth evaluation in children with cystic fibrosis with history of regular use of alternate-day prednisone therapy [abstract]","volume":"28 Suppl 19","author":"Lai","year":"1999","journal-title":"Pediatric Pulmonology"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1542\/peds.87.2.245","article-title":"Risks of alternate-day prednisone in patients with cystic fibrosis","volume":"87","author":"Rosenstein","year":"1991","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0141|cit141","first-page":"350","article-title":"Weight gain associated with low dose olanzapine therapy in severely underweight adults with cystic fibrosis","volume":"40","author":"Ross","year":"2005","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-277X.1995.tb00311.x","article-title":"Growth hormone as a nutritional adjunct in cystic fibrosis: results of a pilot study","volume":"8","author":"Sackey","year":"1995","journal-title":"Journal of Human Nutrition and Dietetics"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0143|cit143","first-page":"104","article-title":"Zinc therapy in children with cystic fibrosis","volume":"27","author":"Safai","year":"1991","journal-title":"Beitrage zur Infusiontherapie"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0144|cit144","first-page":"289","article-title":"The effect of ivacaftor on weight over three years in patients with cf and a G551DCFTR mutation","volume":"49 Suppl 38","author":"Sawicki","year":"2014","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0145|cit145","unstructured":"Schibler A von der Heiden R Birrer P Mullis PE Moderate improved exercise capacity in patients with cystic fibrosis after treatment with recombinant human growth hormone 12th European Respiratory Society Annual Congress; 2002 Sep 14-18; Stockholm, Sweden 2002 P3287"},{"issue":"12","key":"10.1002\/14651858.CD008190.pub3-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/adc.88.12.1078","article-title":"Prospective randomised treatment with recombinant human growth hormone in cystic fibrosis","volume":"88","author":"Schibler","year":"2003","journal-title":"Archives of Disease in Childhood"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0147|cit147","unstructured":"von der Heiden R Kraemer R Birrer P Waldegg G Mullis PE Effect of growth hormone (r-hGH) treatment on working capacity, body composition, lung function and immunological parameters in patients with cystic fibrosis (CF) 21st European Cystic Fibrosis Conference; 1997 Jun 1-6; Davos, Switzerland 1997 132"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1183\/09031936.00103907","article-title":"Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients","volume":"4","author":"Grasemann","year":"2008","journal-title":"European Respiratory Journal"},{"issue":"S29","key":"10.1002\/14651858.CD008190.pub3-BIB0149|cit149","first-page":"335","article-title":"Growth hormone therapy results in increased L-arginine and nitrate concentrations in serum but decreased exhaled nitric oxide in patients with cystic fibrosis","volume":"41","author":"Grasemann","year":"2006","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0150|cit150","unstructured":"Grasemann H Grasemann C Schnabel F Ratjen F Recombinant human growth hormone therapy results in increased systemic nitric oxide (NO) formation but decreased exhaled NO in patients with cystic fibrosis American Thoracic Society 2006 International Conference; 2006 May 19-24; San Diego, CA 2006"},{"issue":"6","key":"10.1002\/14651858.CD008190.pub3-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"e1230","DOI":"10.1542\/peds.2006-2783","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis","volume":"119","author":"Schnabel","year":"2007","journal-title":"Paediatrics"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0152|cit152","first-page":"393","article-title":"A multicenter, randomized, double-blind placebo-controlled trial evaluating the metabolic and respiratory effects of growth hormone in children with cystic fibrosis [abstract]","volume":"41 Suppl 29","author":"Schnabel","year":"2006","journal-title":"Pediatric Pulmonology"},{"issue":"3","key":"10.1002\/14651858.CD008190.pub3-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jhm.874","article-title":"Pilot study of using neutral protamine Hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes","volume":"6","author":"Seggelke","year":"2011","journal-title":"Journal of Hospital Medicine"},{"issue":"8","key":"10.1002\/14651858.CD008190.pub3-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1515\/JPEM.2008.21.8.793","article-title":"Growth hormone therapy improves growth in children with cystic fibrosis-related liver disease","volume":"21","author":"Stalvey","year":"2008","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0155|cit155","first-page":"368","article-title":"Growth hormone effects on pulmonary function in prepubertal children with cystic fibrosis [abstract]","volume":"43 Suppl 31","author":"Geller","year":"2008","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0156|cit156","unstructured":"A study to evaluate nutropin AQ for the treatment of growth restriction in children with cystic fibrosis clinicaltrials.gov\/show\/NCT00079742"},{"issue":"3","key":"10.1002\/14651858.CD008190.pub3-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/ppul.21546","article-title":"A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis","volume":"47","author":"Stalvey","year":"2012","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0158|cit158","first-page":"393","article-title":"Growth hormone (GH) increases height, weight and lean body mass (LBM) in prepubertal children with cystic fibrosis (CF): results of a multicenter randomized control trial [abstract]","volume":"42 Suppl 30","author":"Stalvey","year":"2007","journal-title":"Pediatric Pulmonology"},{"issue":"4","key":"10.1002\/14651858.CD008190.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jcf.2006.10.011","article-title":"Ghrelin and leptin levels in young adults with cystic fibrosis: relationship with body fat","volume":"6","author":"Stylianou","year":"2007","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/j.jcf.2017.07.010","article-title":"Nutrition: prevention and management of nutritional failure in cystic fibrosis","volume":"16 Suppl 2","author":"Sullivan","year":"2017","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1515\/JPEM.2009.22.5.417","article-title":"Insulin-like growth factor-1 levels predict weight, height and protein catabolism in children and adolescents with cystic fibrosis","volume":"22","author":"Switzer","year":"2009","journal-title":"Journal of Pediatric Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0162|cit162","first-page":"389","article-title":"Mirtazapine for appetite stimulation in children with cystic fibrosis [abstract]","volume":"41 Suppl 29","author":"Sykes","year":"2006","journal-title":"Pediatric Pulmonology"},{"issue":"4","key":"10.1002\/14651858.CD008190.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/adc.76.4.304","article-title":"Relation between insulin-like growth factor-I, body mass index and clinical status in cystic fibrosis","volume":"76","author":"Taylor","year":"1997","journal-title":"Archives of Disease in Childhood"},{"issue":"Suppl 48","key":"10.1002\/14651858.CD008190.pub3-BIB0164|cit164","first-page":"P3773","article-title":"One-year pulmonary safety and efficacy of inhaled insulin as adjunctive therapy in type 2 diabetes patients poorly controlled on oral agent monotherapy [abstract]","volume":"24","author":"Teeter","year":"2004","journal-title":"European Respiratory Journal"},{"issue":"8","key":"10.1002\/14651858.CD008190.pub3-BIB0165|cit165","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008901.pub5","article-title":"Recombinant growth hormone therapy for cystic fibrosis in children and young adults","author":"Thaker","year":"2021","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0166|cit166","unstructured":"Tongudai S Braverman S Kirkpatrick JA Huang NN Evaluation of oxandrolone in patients with cystic fibrosis 12th Annual Meeting Cystic Fibrosis Club Abstracts; 1971 Apr 28; Atlantic City (NJ) 1971 54"},{"issue":"3","key":"10.1002\/14651858.CD008190.pub3-BIB0167|cit167","first-page":"237","article-title":"Growth hormone normalizes pubertal onset in children with cystic fibrosis","volume":"19","author":"Vanderwel","year":"2006","journal-title":"Journal of Pediatric\u00a0Endocrinology & Metabolism"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S1569-1993(21)01199-1","article-title":"Investigation of cyproheptadine as an appetite stimulator in 6 children with cystic fibrosis with a suboptimal nutritional status","volume":"20 Suppl 1","author":"Van Meerbeeck","year":"2021","journal-title":"Journal of Cystic Fibrosis"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0169|cit169","unstructured":"Varness T Seffrood EE Connor EL Rock MJ Allen DB Oxandrolone improves height velocity and BMI in patients with cystic fibrosis International Journal of Pediatric Endocrinology 10.1155\/2009\/826895"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0170|cit170","unstructured":"CF-IDEA (cystic fibrosis - insulin deficiency, early action): randomised controlled trial of once-daily insulin detemir in patients with cystic fibrosis and early insulin deficiency trialsearch.who.int\/Trial2.aspx?TrialID=ACTRN12611000068965"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0171|cit171","unstructured":"Cystic Fibrosis - Insulin Deficiency, Early Action clinicaltrials.gov\/show\/NCT01100892"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0172|cit172","first-page":"15","article-title":"Cystic Fibrosis - Insulin Deficiency, Early Action","volume":"16 Suppl 21","author":"Verge","year":"2015","journal-title":"Pediatric Diabetes"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/S1569-1993(13)60204-0","article-title":"Oral reduced L-glutathione improves weight and calprotectin in pediatric cystic fibrosis patients","volume":"12 Suppl 1","author":"Visca","year":"2013","journal-title":"Journal of Cystic Fibrosis"},{"issue":"3","key":"10.1002\/14651858.CD008190.pub3-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pharmthera.2008.09.009","article-title":"Cardiac cachexia: a systematic overview","volume":"121","author":"Haehling","year":"2009","journal-title":"Pharmacology & Therapeutics"},{"issue":"4","key":"10.1002\/14651858.CD008190.pub3-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1378\/chest.121.4.1070","article-title":"Megesterol acetate stimulates weight gain and ventilation in underweight COPD patients","volume":"121","author":"Weisberg","year":"2002","journal-title":"Chest"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0176|cit176","first-page":"326","article-title":"The role of mirtazapine as an appetite stimulant in malnourished individuals with CF [abstract]","volume":"30 Suppl 20","author":"Young","year":"2000","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0177|cit177","unstructured":"Ghrelin in cystic fibrosis (ghrelin) clinicaltrials.gov\/ct2\/show\/NCT00763477"},{"issue":"3","key":"10.1002\/14651858.CD008190.pub3-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jcf.2011.11.005","article-title":"Patient indicators of a pulmonary exacerbation: preliminary reports from school aged children map onto those of adults","volume":"11","author":"Abbott","year":"2012","journal-title":"Journal of Cystic Fibrosis"},{"issue":"7","key":"10.1002\/14651858.CD008190.pub3-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jand.2020.03.014","article-title":"Effect of CFTR modulators on anthropometric parameters in individuals with cystic fibrosis: an evidence analysis center systematic review","volume":"121","author":"Bailey","year":"2021","journal-title":"Journal of the Academy of Nutrition and Dietetics"},{"issue":"4","key":"10.1002\/14651858.CD008190.pub3-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE Guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0261-5614(98)80061-7","article-title":"Nutrition in adults with cystic fibrosis","volume":"17","author":"Bell","year":"1998","journal-title":"Clinical Nutrition"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0182|cit182","unstructured":"British National Formulary Periactin www.medicinescomplete.com\/mc\/bnf\/current\/PHP1940-periactin.htm#PHP1940-periactin"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0183|cit183","volume-title":"British National Formulary No 82","author":"Joint Formulary Committee","year":"2021"},{"issue":"6","key":"10.1002\/14651858.CD008190.pub3-BIB0184|cit184","first-page":"457","article-title":"The interrelationship of nutrition and pulmonary function in patients with cystic fibrosis","volume":"2","author":"Borowitz","year":"1996","journal-title":"Current Opinion in Pulmonary Medicine"},{"issue":"6","key":"10.1002\/14651858.CD008190.pub3-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/0895-4356(88)90063-7","article-title":"A comparison of survival, growth and pulmonary function in patients with CF in Boston and Toronto","volume":"41","author":"Corey","year":"1998","journal-title":"Journal of Clinical Epidemiology"},{"issue":"15","key":"10.1002\/14651858.CD008190.pub3-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1002\/sim.1205","article-title":"Meta-analysis combining parallel and cross-over clinical trials. I: Continuous outcomes","volume":"21","author":"Curtin","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"15","key":"10.1002\/14651858.CD008190.pub3-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/sim.1206","article-title":"Meta-analysis combining parallel and cross-over clinical trials. II: Binary outcomes","volume":"21","author":"Curtin","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"15","key":"10.1002\/14651858.CD008190.pub3-BIB0188|cit188","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/sim.1207","article-title":"Meta-analysis combining parallel and cross-over clinical trials. III: The issue of carryover","volume":"21","author":"Curtin","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"10","key":"10.1002\/14651858.CD008190.pub3-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"971-2","DOI":"10.1136\/thx.51.10.971","article-title":"Nutrition and survival in cystic fibrosis","volume":"51","author":"Elborn","year":"1996","journal-title":"Thorax"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0191|cit191","unstructured":"Nabilone tablets 1 mg www.medicines.org.uk\/emc\/medicine\/20515\/SPC\/Nabilone+1mg+Capsules"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0192|cit192","unstructured":"Megace 160 mg tablets www.medicines.org.uk\/emc\/medicine\/346\/SPC\/Megace+160+mg+Tablets"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0193|cit193","unstructured":"Mirtazapine 15 mg tablets www.medicines.org.uk\/emc\/medicine\/24969\/SPC\/Mirtazapine+15+mg+orodispersible+tablets"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0194|cit194","unstructured":"Olanzapine Sandoz 20 mg film-coated tablets www.medicines.org.uk\/emc\/medicine\/25455\/SPC\/Olanzapine+Sandoz+20+mg+Film-coated+Tablets"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0195|cit195","unstructured":"Pizotifen tablets 0.5 mg www.medicines.org.uk\/emc\/medicine\/24179\/SPC\/Pizotifen+Tablets+0.5mg\/"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0196|cit196","unstructured":"Risperdal Tablets, Liquid & Quicklet www.medicines.org.uk\/emc\/medicine\/12818\/SPC"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.physbeh.2010.03.011","article-title":"Hypothalamic mechanisms in cachexia","volume":"100","author":"Grossberg","year":"2010","journal-title":"Physiology and Behavior"},{"issue":"Suppl 2","key":"10.1002\/14651858.CD008190.pub3-BIB0198|cit198","first-page":"731","article-title":"Growth problems and growth hormone treatment in children with cystic fibrosis","volume":"15","author":"Hardin","year":"2002","journal-title":"Journal of Pediatric Endocrinology & Metabolism"},{"issue":"7414","key":"10.1002\/14651858.CD008190.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0200|cit200","unstructured":"Higgins JP Altman DG Sterne JA on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"6","key":"10.1002\/14651858.CD008190.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.jrn.2010.01.010","article-title":"Megestrol acetate improves weight gain in pediatric patients with chronic kidney disease","volume":"20","author":"Hobbs","year":"2012","journal-title":"Journal of Renal Nutrition"},{"issue":"10","key":"10.1002\/14651858.CD008190.pub3-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0203|cit203","unstructured":"Jones AP Riley R Williamson PR Whitehead A Meta-analysis of longitudinal data Royal Statistical Society Annual Conference; 2005 Jul 18-21; Cardiff, UK 2005"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/ppul.10184","article-title":"Adrenal insufficiency and testicular failure secondary to megesterol acetate therapy in a patient with cystic fibrosis","volume":"34","author":"McKone","year":"2002","journal-title":"Pediatric Pulmonology"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0205|cit205","unstructured":"MedLibrary (Food & Drug Agency) Oxandrolone www.medlibrary.org\/lib\/info\/google-search\/?cx=partner-pub-3862246084592963%3A1mitg9hzsad&cof=FORID%3A10&ie=UTF-8&q=oxandrolone&sa=Search&siteurl=medlibrary.org%2F&ref=&ss=4143j3496931j13"},{"issue":"9263","key":"10.1002\/14651858.CD008190.pub3-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(00)04337-3","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials","volume":"357","author":"Moher","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD008190.pub3-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00784-002-0188-x","article-title":"The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials","volume":"7","author":"Moher","year":"2003","journal-title":"Clinical Oral Investigations"},{"issue":"4","key":"10.1002\/14651858.CD008190.pub3-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1503\/cmaj.1040031","article-title":"Opportunities and challenges for improving the quality of reporting clinical research: CONSORT and beyond","volume":"171","author":"Moher","year":"2004","journal-title":"Canadian Medical Association Journal"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/0884533612466113","article-title":"A survey of nutrition practices for patients with cystic fibrosis","volume":"28","author":"O'Brien","year":"2013","journal-title":"Nutrition in Clinical Practice"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1183\/09031936.05.00035205","article-title":"Interpretative strategies for lung function tests","volume":"26","author":"Pellegrino","year":"2005","journal-title":"European Respiratory Journal"},{"issue":"7542","key":"10.1002\/14651858.CD008190.pub3-BIB0211|cit211","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1136\/bmj.38737.600880.AE","article-title":"Oral protein energy supplements for children with cystic fibrosis: CALICO multicentre randomised controlled trial","volume":"332","author":"Poustie","year":"2006","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0212|cit212","unstructured":"Review Manager (RevMan Web) The Cochrane Collaboration 2022"},{"issue":"10","key":"10.1002\/14651858.CD008190.pub3-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/thorax.56.10.746","article-title":"Wasting as an independent predictor of mortality in patients with cystic fibrosis","volume":"56","author":"Sharma","year":"2001","journal-title":"Thorax"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/ajcn\/48.2.235","article-title":"Short-term nutritional supplementation during management of pulmonary exacerbations in cystic fibrosis: a controlled study, including effects of protein turnover","volume":"48","author":"Shepherd","year":"1998","journal-title":"American Journal of Clinical Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1569-1993(02)00032-2","article-title":"Nutrition in patients with cystic fibrosis: a European Consensus","volume":"1","author":"Sinaasappel","year":"2002","journal-title":"Journal of Cystic Fibrosis"},{"issue":"5","key":"10.1002\/14651858.CD008190.pub3-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.jada.2008.02.020","article-title":"Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review","volume":"108","author":"Stallings","year":"2008","journal-title":"Journal of the American Dietetic Association"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/thorax.57.7.596","article-title":"Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project","volume":"57","author":"Steinkamp","year":"2002","journal-title":"Thorax"},{"issue":"6","key":"10.1002\/14651858.CD008190.pub3-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1164\/ajrccm\/140.6.1640","article-title":"Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis","volume":"140","author":"Suter","year":"1989","journal-title":"American Review of Respiratory Disease"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0219|cit219","unstructured":"Tayor C The regulation of appetite in cystic fibrosis symposium 30th Congress European Cystic Fibrosis Society; 2007 Jun 13-16; Belek, Turkey 2007"},{"issue":"2","key":"10.1002\/14651858.CD008190.pub3-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1034\/j.1600-6143.2002.020208.x","article-title":"Osteoporosis before lung transplantation: association with low body mass index, but not with underlying disease","volume":"2","author":"Tschopp","year":"2002","journal-title":"American Journal of Transplantation"},{"key":"10.1002\/14651858.CD008190.pub3-BIB0221|cit221","unstructured":"Oxandrolone tablets www.upsher-smith.com\/products\/oxandrolone-tablets-usp-ciii\/"},{"issue":"3","key":"10.1002\/14651858.CD008190.pub3-BIB0222|cit222","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.pharmthera.2008.09.009","article-title":"Cardiac cachexia: a systematic overview","volume":"121","author":"Haehling","year":"2009","journal-title":"Pharmacology & Therapeutics"},{"issue":"12","key":"10.1002\/14651858.CD008190.pub3-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4065\/79.12.1557","article-title":"Osteoporosis associated with megesterol acetate","volume":"79","author":"Wermers","year":"2004","journal-title":"Mayo Clinic Proceedings"},{"issue":"7","key":"10.1002\/14651858.CD008190.pub3-BIB0224|cit224","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008190.pub2","article-title":"Appetite stimulants for people with cystic fibrosis","author":"Chinuck","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T08:19:11Z","timestamp":1693988351000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD008190.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":225,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd008190.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}